RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS)
Clinical trials for RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS) explained in plain language.
Never miss a new study
Get alerted when new RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS) trials appear
Sign up with your email to follow new studies for RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New MS drug candidate ABP 692 faces off against ocrevus in major trial
Disease control OngoingThis study tests whether a new drug, ABP 692, works as well as the approved drug Ocrevus for people with relapsing-remitting multiple sclerosis (RRMS). About 152 adults with RRMS will receive either ABP 692 or Ocrevus to compare how the drugs move through the body and how well th…
Matched conditions: RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS)
Phase: PHASE3 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
MS patients on ozanimod: how long does treatment last?
Disease control OngoingThis study follows about 200 people with relapsing-remitting multiple sclerosis (RRMS) who are starting ozanimod (Zeposia®) for the first time. Researchers want to see how long patients continue the medication in everyday practice and how well it controls their disease. The study…
Matched conditions: RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS)
Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Could stem cells ease MS symptoms? new trial tests hope
Disease control OngoingThis study tests a stem cell treatment (HB-adMSCs) for people with relapsing-remitting multiple sclerosis. The goal is to see if multiple infusions can improve quality of life and slow disability. Ten adults who previously received a placebo in an earlier trial will receive the t…
Matched conditions: RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS)
Phase: PHASE2 • Sponsor: Hope Biosciences Research Foundation • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Hidden hunger in MS: new study probes link between malnutrition and disability
Knowledge-focused OngoingThis observational study measures how common malnutrition is in people with relapsing-remitting multiple sclerosis (RRMS) and whether it is linked to disability. Researchers will assess nutritional status, body composition, and other factors like depression and incontinence in 16…
Matched conditions: RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS)
Sponsor: Antalya Training and Research Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC